| Empagliflozin in Hypertrophic Cardiomyopathy (NCT05182658) | National Institute of Cardiology, Warsaw, Poland | 2022-06-01 |
| Exercise Oxygen Kinetic and Cardiac Output in Hypertrophic Cardiomyopathy (NCT05754489) | Centro Cardiologico Monzino | 2022-04-20 |
| Anesthetic Management for TA-BSM in HOCM (NCT06397092) | Tongji Hospital | 2022-04-01 |
| Electromechanically Optimised Right Ventricular Pacing In Hypertrophic Cardiomyopathy (EMORI-HCM) (NCT05257772) | Imperial College London | 2022-03-14 |
| Viz HCM (ECG Assist) Utilization Workflow Pilot (NCT06600256) | Viz.ai, Inc. | 2022-01-10 |
| Comparison of Squat-to-Stand Maneuver With Amyl Nitrite, Valsalva, and Exercise Stress Echocardiography in Inducing Latent Left Ventricular Outflow Obstruction in Hypertrophic Cardiomyopathy (NCT04905173) | Mayo Clinic | 2021-11-01 |
| Study Evaluating the Pharmacokinetics of Mavacamten in Healthy Adult Chinese Subjects (NCT05135871) | LianBio LLC | 2021-10-31 |
| Surgical Septal Myectomy vs Percutaneous Transluminal Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy (NCT04684290) | St. Antonius Hospital | 2021-06-30 |
| Paced Dyssynchrony and Myocardial Perfusion IN apiCal Hcm (NCT04231032) | Barts & The London NHS Trust | 2021-06-02 |
| Hypertrophic Cardiomyopathy Registry, Biobank and Imaging Data Repository (NCT05100420) | Montreal Heart Institute | 2021-02-23 |
| Healthy-related Quality of Life and Physical Activity of Children With Cardiac Malformations (NCT04712136) | University Hospital, Montpellier | 2021-02-01 |
| The Efficacy and Mechanism of Trientine in Patients With Hypertrophic Cardiomyopathy (NCT04706429) | Manchester University NHS Foundation Trust | 2020-12-01 |
| Role of Perhexiline in Hypertrophic Cardiomyopathy (NCT04426578) | Flinders University | 2020-12-01 |
| Intraventricular Stasis In Cardiovascular Disease (NCT04649034) | Hospital General Universitario Gregorio Marañon | 2020-11-24 |
| Optimisation of Decision Making for Defibrillator Implantation in Hypertrophic Cardiomyopathy (NCT03846297) | Assistance Publique - Hôpitaux de Paris | 2020-09-23 |
| OPIE in the Thin Interventricular Septum (NCT04050579) | NYU Langone Health | 2020-09-15 |
| Physical Activity in Children With Inherited Cardiac Diseases (NCT04650009) | University Hospital, Montpellier | 2020-05-01 |
| Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic Cardiomyopathy (NCT04133532) | University Hospital, Motol | 2020-03-05 |
| Extended ECG Monitoring in HCM Patients (NCT04056715) | iRhythm Technologies, Inc. | 2020-01-14 |
| Non-Invasive Radiation Ablation in Patients With Hypertrophic CardioMyopathy: NIRA-HOCM (NCT04153162) | Barts & The London NHS Trust | 2020-01-07 |
| A 10-Minute Cardiovascular Magnetic Resonance Protocol for Cardiac Disease (NCT04464655) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2019-12-12 |
| Prospective Evaluation Of Exercise-Induced Cardiac Conduction Instability In Predicting Ventricular Fibrillation Events In Hypertrophic Cardiomyopathy (NCT04157205) | Imperial College London | 2019-11-10 |
| A Prospective Incident Study of Arrhythmias in Hypertrophic Cardiomyopathy (NCT04112290) | Mayo Clinic | 2019-11-05 |
| Assessment of the Relations Between Endothelial and Venous Dysfunctions and Left Ventricular Obstruction in Genetic Hypertrophic Cardiomyopathies (NCT04129905) | University Hospital, Bordeaux | 2019-10-22 |
| HCM-AF Ablation With ACUTUS (NCT04090437) | Royal Brompton & Harefield NHS Foundation Trust | 2019-10-01 |
| CVD Risk Profile in Children With HCM (NCT05510180) | University of Alberta | 2019-05-21 |
| Sacubitril/Valsartan vs Lifestyle in Hypertrophic Cardiomyopathy (NCT03832660) | Newcastle University | 2019-05-03 |
| Lifestyle and Pharmacological Interventions in Hypertrophic Cardiomyopathy (NCT05366101) | Newcastle-upon-Tyne Hospitals NHS Trust | 2019-04-01 |
| Incidence of Hypertrophic Cardiomyopathy in Infants of Diabetic Mothers Attending in NICU at Assiut University Children Hospital During One Year (NCT06048562) | Assiut University | 2019-03-20 |
| 3D Non-invasive Myocardial Electrical Propagation Mapping as a New Tool to Predict Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy (NCT03550573) | Hospices Civils de Lyon | 2019-01-28 |
| Efficacy of Psychotherapy for Improving Quality of Life in Patients With Hypertrophic Cardiomyopathy and Depression (NCT03706001) | Xijing Hospital | 2018-10-20 |
| A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM (NCT03723655) | Bristol-Myers Squibb | 2018-09-27 |
| Will Elevated Left Ventricle Filling Pressures Decrease by a Group Exercise Program in Patients With Hypertrophic CardioMyopathy? (NCT03537183) | Bispebjerg Hospital | 2018-09-01 |
| Genomic Sequencing in Patients With HCM Undergoing Septal Myectomy (NCT03043209) | The Cleveland Clinic | 2018-08-30 |
| Sahlgrenska Cardiomyopathy Project (NCT03527342) | Göteborg University | 2018-06-01 |
| Manganese-Enhanced Magnetic Resonance Imaging of the Myocardium (NCT03607669) | University of Edinburgh | 2018-06-01 |
| Evaluating the Effect of Spironolactone on Hypertrophic Cardiomyopathy (NCT02948998) | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2018-05-14 |
| The Effect of Metoprolol in Patients With Hypertrophic Obstructive Cardiomyopathy. (NCT03532802) | Steen Hvitfeldt Poulsen | 2018-05-01 |
| Extension Study of Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Previously Enrolled in PIONEER (NCT03496168) | Bristol-Myers Squibb | 2018-04-26 |
| High Intensity Exercise for Increasing Fitness in Patients With Hypertrophic Cardiomyopathy (NCT03335332) | University of Texas Southwestern Medical Center | 2018-01-31 |
| Exercise Training in Hypertrophic Cardiomyopathy: (SAFE-HCM) (NCT05459467) | St George's, University of London | 2018-01-01 |
| Correlation Between Myocardial Deformation and Coronary Artery Tortuosity in Patients With Hypertrophic Cardiomyopathy (NCT04830787) | Henan Provincial People's Hospital | 2017-12-01 |
| Sleep Apnea and Hypertrophic Cardiomyopathy (HCM) (NCT03327623) | Mayo Clinic | 2017-11-13 |
| Microvascular Dysfunction in Nonischemic Cardiomyopathy: Insights From CMR Assessment of Coronary Flow Reserve (NCT03249272) | Duke University | 2017-09-05 |
| Insertable Cardiac Monitors in Hypertrophic Cardiomyopathy (NCT03259113) | Region Gävleborg | 2017-08-16 |
| Differentiation HHD From HCM (EARLY-MYO-HHD) (NCT03271385) | RenJi Hospital | 2017-07-01 |
| Presentations of Hypertrophic Cardiomyopathy on Myocardial Perfusion Imaging (NCT03150342) | Far Eastern Memorial Hospital | 2017-05-08 |
| Functional Capacity and Quality of Life Following Septal Myectomy in Patients With HCM (NCT03092843) | The Cleveland Clinic | 2017-03-20 |
| PRecIsion Medicine in CardiomyopathY (NCT04036799) | The Hospital for Sick Children | 2017-01-01 |
| Evaluating Microvascular Dysfunction in Symptomatic Patients With HypertroPhic CaRdiomyopathy (NCT02994615) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2017-01-01 |
| Prognostic Value of Angio-IMR in Hypertrophic Cardiomyopathy Patients (NCT06434415) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2017-01-01 |
| Extended Ambulatory Monitoring Improves Risk Stratification in Hypertrophic Cardiomyopathy (NCT03182153) | Atlantic Health System | 2016-11-01 |
| Metabolomic Study of All-age Cardiomyopathy (NCT03061994) | Beijing Institute of Heart, Lung and Blood Vessel Diseases | 2016-10-01 |
| Hypertrophic Cardiomyopathy Pilot Study (NCT02806479) | Oregon Health and Science University | 2016-09-01 |
| Mitral Valve Management During Septal Myectomy (NCT03906734) | Meshalkin Research Institute of Pathology of Circulation | 2016-01-10 |
| Perfusion Imaging With Myocardial Contrast Echocardiography in HCM (NCT02560467) | Oregon Health and Science University | 2015-12-01 |
| Non-Invasive Evaluation of Myocardial Stiffness by Elastography in Pediatric Cardiology (Elasto-Pédiatrie) (NCT02619825) | French Cardiology Society | 2015-11-01 |
| Hypertrophic Cardiomyopathy Symptom Release by BX1514M (NCT02590809) | University Hospital, Bordeaux | 2015-10-07 |
| An Integrative-"Omics" Study of Cardiomyopathy Patients for Diagnosis and Prognosis in China (NCT03076580) | Beijing Institute of Heart, Lung and Blood Vessel Diseases | 2015-07-01 |
| New Diagnostic Strategy in Hypertrophic Cardiomyopathy (NCT02520856) | Assistance Publique Hopitaux De Marseille | 2015-07-01 |
| Hyper-synchronicity in Hypertrophic Cardiomyopathy (HCM) : Description, Mechanism and Origin With a Multi-imaging Approach to Predict Dual Chamber Pacing Response (NCT02559726) | University Hospital, Bordeaux | 2015-06-22 |
| Exercise in Genetic Cardiovascular Conditions (NCT02549664) | Yale University | 2015-05-01 |
| Morbidity and Mortality in Patients With Hypertrophic Cardiomyopathy: a CALIBER Study (NCT02424994) | University College, London | 2015-04-01 |
| Study of Myocardial Deformation Parameters in Patients With Hypertrophic Cardiomyopathy (NCT04112511) | AHEPA University Hospital | 2015-03-01 |
| Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy (NCT02291237) | Gilead Sciences | 2015-02-05 |
| Study of Hypertrophic Cardiomyopathy Under Stress Conditions. Concordance Between Two Complementary Tests: Stress MRI and Exercice Stress Echocardiography (NCT02500420) | University Hospital, Montpellier | 2014-12-01 |
| Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461 (NCT02329184) | MyoKardia, Inc. | 2014-12-01 |
| Assessment of Wall Thickness in Hypertrophic Cardiomyopathy (NCT02234336) | Mayo Clinic | 2014-10-01 |
| Efficacy of Risk Assessment for Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy (NCT04402268) | Poznan University of Medical Sciences | 2014-10-01 |
| Predictive Factors and Consequences of Myocardial Fibrosis in Hypertrophic Cardiomyopathy (NCT02922517) | Nantes University Hospital | 2014-06-01 |
| HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy (NCT01915615) | University of Virginia | 2014-04-01 |
| Pediatric Cardiomyopathy Mutation Analysis (NCT02432092) | Indiana University | 2014-04-01 |
| Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM (NCT01912534) | Carelon Research | 2014-03-01 |
| Egyptian Hypertrophic Cardiomyopathy Program (NCT05884892) | Magdi Yacoub Heart Foundation | 2014-01-01 |
| Molecular and Imaging Studies of Cardiovascular Health and Disease (NCT02804269) | National Heart Centre Singapore | 2013-07-01 |
| Cardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers) (NCT01873976) | Wayne State University | 2013-06-01 |
| Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES) (NCT01873963) | Wayne State University | 2013-04-01 |
| Risk Stratification in Children and Adolescents With Primary Cardiomyopathy (NCT03572569) | German Heart Institute | 2013-01-01 |
| Ranolazine for the Treatment of Chest Pain in HCM Patients (NCT01721967) | Duke University | 2012-11-01 |
| A Biomarker and MRI Study on Troponin Release After Exercise in Hypertrophic Cardiomyopathy (NCT01559714) | Heartcenter, University Medical Center St. Radboud | 2012-04-01 |
| Trimetazidine Therapy in Hypertrophic Cardiomyopathy (NCT01696370) | University College, London | 2012-04-01 |
| Hypertrophic Regression With N-Acetylcysteine in HCM (NCT01537926) | The University of Texas Health Science Center, Houston | 2012-01-01 |
| Exercise Training in Patients With Hypertrophic Cardiomyopathy (NCT01518114) | Sheba Medical Center | 2011-12-01 |
| Study to Develop a Non-invasive Marker for Monitoring Myocardial Fibrosis (NCT01230918) | Ottawa Heart Institute Research Corporation | 2011-05-01 |
| Outcome of Different Pathogenic Mutations in Hypertrophic Cardiomyopathy (NCT03726424) | Tongji Hospital | 2011-02-25 |
| Biomarkers in Aortic Stenosis - B.A.S.S. (NCT01334801) | Mayo Clinic | 2010-07-01 |
| Biventricular Pacing in Hypertrophic Cardiomyopathy After Aortic Valve Replacement (NCT01081093) | Johann Wolfgang Goethe University Hospital | 2010-04-01 |
| French Hypertrophic Cardiomyopathy Observatory (NCT01091480) | French Cardiology Society | 2010-01-01 |
| Refining Information Technology Support for Genetics in Medicine (NCT01225978) | Brigham and Women's Hospital | 2009-09-01 |
| Genetic Predictors of Outcome in HCM Patients (NCT00156429) | University of Pittsburgh | 2009-04-22 |
| Antiarrhythmic Therapy Versus Catheter Ablation for Atrial Fibrillation in Hypertrophic Cardiomyopathy (NCT00821353) | National Institute of Cardiology, Warsaw, Poland | 2009-01-01 |
| Outcomes of Concomitant Bypass Surgery in Septal Myectomy (NCT06354413) | Chinese Academy of Medical Sciences, Fuwai Hospital | 2009-01-01 |
| Clinical and Therapeutic Implications of Fibrosis in Hypertrophic Cardiomyopathy (NCT00879060) | Tufts Medical Center | 2007-11-01 |
| Use of Magnetic Field Mapping in the Evaluation of Patients With Hypertrophic Heart Disease (Thick Heart Muscle) (NCT00574821) | Cedars-Sinai Medical Center | 2007-07-01 |
| The Genetics of Cardiomyopathy and Heart Failure (NCT00703443) | University of California, Irvine | 2007-04-01 |
| Study to Determine if Atorvastatin Reduces Size and Stiffness of Muscle in the Left Ventricle of the Heart (NCT00317967) | University of Calgary | 2007-04-01 |
| Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy (NCT01150461) | Massachusetts General Hospital | 2007-02-01 |
| Perhexiline Therapy in Patients With Hypertrophic Cardiomyopathy (NCT00500552) | University Hospital Birmingham | 2006-12-01 |
| Biventricular Pacing in Hypertrophic Cardiomyopathy (NCT00504647) | University Hospital Birmingham | 2006-06-01 |
| Comparison of Data Obtained by Echocardiography and Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy (NCT00315783) | Assistance Publique - Hôpitaux de Paris | 2006-04-01 |